On 16 February, CTI BioPharma Corp. (NASDAQ:CTIC) reported a loss of $25.6 million in its fourth quarter. The Seattle-based company said it had a loss of 13 cents per share. Losses, adjusted for stock option expense, were 12 cents per share. The biotechnology company posted revenue of $11.3 million in the period. For the year, the company reported that its loss widened to $119.4 million, or 65 cents per share. Revenue was reported as $16.1 million.
CTI BioPharma Corp. (NASDAQ:CTIC) belongs to Healthcare sector. Its weekly performance is 33.62%. On last trading day company shares ended up at $0.67.
On February 8, 2016, the Organization and Compensation Committee (the “Committee”) of the Board of Directors of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Approved 2015 annual cash bonus awards pursuant to the Company’s annual cash bonus program and Established based on a determination that the corporate objectives had been achieved at a level of 60%, the individual objectives had been achieved at a level of 60% and the general management contribution had been achieved at a level of 66.7%.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) shares fell -1.13% in last trading session and ended the day at $5.27. MACK return on assets is -89.00%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) quarterly performance is -36.12%.
Brookline Bancorp, Inc. (NASDAQ:BRKL) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday, ARN reports. The firm presently has a $12.00 price objective on the stock. Zacks Investment Research‘s price target indicates a potential upside of 15.50% from the company’s current price.
On 24 February, Brookline Bancorp, Inc. (NASDAQ:BRKL) shares fell -0.10% and was closed at $10.29. BRKL EPS growth in last 5 year was 9.10%. Brookline Bancorp, Inc. (NASDAQ:BRKL) year to date (YTD) performance is -9.76%.
Grupo Televisa, S.A.B. (NYSE:TV) ended the last trading day at $25.27. Company weekly volatility is calculated as 2.83% and price to cash ratio as 8.03. Grupo Televisa, S.A.B. (NYSE:TV) showed a weekly performance of 0.48%.
Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) today announced that a class action has been commenced in the United States District Court for the Southern District of Florida on behalf of stockholders of Jarden Corporation (“Jarden”) (NYSE:JAH) on December 14, 2015, in connection with the proposed acquisition of Jarden by Newell Rubbermaid Inc. (“Newell”) and its affiliates NCPF Acquisition Corp. I (“Merger Sub 1”) and NCPF Acquisition Corp. II (“Merger Sub 2”) (the “Proposed Acquisition”).
Jarden Corp. (NYSE:JAH) shares fell -0.02% in last trading session and ended the day at $52.43. JAH Gross Margin is 31.40% and its return on assets is 2.00%. Jarden Corp. (NYSE:JAH) quarterly performance is 13.17%.